BIKTARVY 30-120-15 MG TABLET

FDA nonproprietary name: bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate

For 30 tablets

Pharmacies pay

$4,099.65 filed

30 × $136.65502 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.

The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$4,719.60 estimated

$4,099.65 + $614.95 (15%) + $5.00 fee per fill = $4,719.60

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BIKTARVY 30-120-15 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, under the trade name “Biktarvy”.

FDA gives its dosage form as tablet and its route as oral.

The labeler, the company named on the label, is Gilead Sciences, Inc.

FDA lists it under 2 Established Pharmacologic Classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor and Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $4,099.65 for 30 tablets (30 × $136.65502 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

All 2 NDCs

61958-2505-01 · Gilead Sciences, Inc. · $136.65502 per EA · eff. 2026-09-23 filed
61958-2506-01 · Gilead Sciences, Inc. · $136.65502 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate with BIKTARVY 30-120-15 MG TABLET.

Product	Pharmacies pay per unit	Medicare per unit
BIKTARVY 30-120-15 MG TABLET this page brand · tablet	$136.65502 per EA filed eff. 2026-09-23	We don’t know yet
BIKTARVY 50-200-25 MG TABLET brand · tablet	$136.7284 per EA filed eff. 2026-09-23	We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $136.65502 per EA filed.

Of the 28 other products in FDA’s Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class priced per EA, 4 have a higher middle NADAC price and 24 a lower one. The one in the middle is BARACLUDE 0.5 MG TABLET, at $44.18654 per EA filed (eff. 2025-11-19).

Of the 28 other products in FDA’s Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor class priced per EA, 4 have a higher middle NADAC price and 24 a lower one. The one in the middle is VIREAD 300 MG TABLET, at $40.6865 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-11-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.